Extracellular Matrix Remodeling Biomarkers in Coronary Artery Disease

Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.; Catapano, A.L.; Chugh, S.S.; Cooper, L.T.; Coresh, J.; Criqui, M.; DeCleene, N.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Solà, J.; Fowkes, G.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.; Koroshetz, W.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Temesgen, A.M.; Mokdad, A.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Moraes de Oliveira, G.; Otto, C.; Owolabi, M.; Pratt, M.; Rajagopalan, S.; Reitsma, M.; Ribeiro, A.L.P.; Rigotti, N.; Rodgers, A.; Sable, C.; Shakil, S.; Sliwa-Hahnle, K.; Stark, B.; Sundström, J.; Timpel, P.; Tleyjeh, I.M.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.; Murray, C.; Fuster, V.; Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.R.; Catapano, A.L.; Chugh, S.; Cooper, L.T.; Coresh, J.; Criqui, M.H.; DeCleene, N.K.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Sola, J.; Fowkes, F.G.R.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.J.; Koroshetz, W.J.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Misganaw, A.T.; Mokdad, A.H.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Oliveira, G.M.M.; Otto, C.M.; Owolabi, M.O.; Pratt, M.; Rajagopalan, S.; Reitsma, M.B.; Ribeiro, A.L.P.; Rigotti, N.A.; Rodgers, A.; Sable, C.A.; Shakil, S.S.; Sliwa, K.; Stark, B.A.; Sundström, J.; Timpel, P.; Tleyjeh, I.I.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.J.; Abbasi-Kangevari, M.; Abdi, A.; Abedi, A.; Aboyans, V.; Abrha, W.A.; Abu-Gharbieh, E.; Abushouk, A.I.; Acharya, D.; Adair, T.; Adebayo, O.M.; Ademi, Z.; Advani, S.M.; Afshari, K.; Afshin, A.; Agarwal, G.; Agasthi, P.; Ahmad, S.; Ahmadi, S.; Ahmed, M.B.; Aji, B.; Akalu, Y.; Akande-Sholabi, W.; Aklilu, A.; Akunna, C.J.; Alahdab, F.; Al-Eyadhy, A.; Alhabib, K.F.; Alif, S.M.; Alipour, V.; Aljunid, S.M.; Alla, F.; Almasi-Hashiani, A.; Almustanyir, S.; Al-Raddadi, R.M.; Amegah, A.K.; Amini, S.; Aminorroaya, A.; Amu, H.; Amugsi, D.A.; Ancuceanu, R.; Anderlini, D.; Andrei, T.; Andrei, C.L.; Ansari-Moghaddam, A.; Anteneh, Z.A.; Antonazzo, I.C.; Antony, B.; Anwer, R.; Appiah, L.T.; Arabloo, J.; Ärnlöv, J.; Artanti, K.D.; Ataro, Z.; Ausloos, M.; Avila-Burgos, L.; Awan, A.T.; Awoke, M.A.; Ayele, H.T.; Ayza, M.A.; Azari, S. B, D.B.; Baheiraei, N.; Baig, A.A.; Bakhtiari, A.; Banach, M.; Banik, P.C.; Baptista, E.A.; Barboza, M.A.; Barua, L.; Basu, S.; Bedi, N.; Béjot, Y.; Bennett, D.A.; Bensenor, I.M.; Berman, A.E.; Bezabih, Y.M.; Bhagavathula, A.S.; Bhaskar, S.; Bhattacharyya, K.; Bijani, A.; Bikbov, B.; Birhanu, M.M.; Boloor, A.; Brant, L.C.; Brenner, H.; Briko, N.I.; Butt, Z.A.; Caetano dos Santos, F.L.; Cahill, L.E.; Cahuana-Hurtado, L.; Cámera, L.A.; Campos-Nonato, I.R.; Cantu-Brito, C.; Car, J.; Carrero, J.J.; Carvalho, F.; Castañeda-Orjuela, C.A.; Catalá-López, F.; Cerin, E.; Charan, J.; Chattu, V.K.; Chen, S.; Chin, K.L.; Choi, J-Y.J.; Chu, D-T.; Chung, S-C.; Cirillo, M.; Coffey, S.; Conti, S.; Costa, V.M.; Cundiff, D.K.; Dadras, O.; Dagnew, B.; Dai, X.; Damasceno, A.A.M.; Dandona, L.; Dandona, R.; Davletov, K.; De la Cruz-Góngora, V.; De la Hoz, F.P.; De Neve, J-W.; Denova-Gutiérrez, E.; Derbew Molla, M.; Derseh, B.T.; Desai, R.; Deuschl, G.; Dharmaratne, S.D.; Dhimal, M.; Dhungana, R.R.; Dianatinasab, M.; Diaz, D.; Djalalinia, S.; Dokova, K.; Douiri, A.; Duncan, B.B.; Duraes, A.R.; Eagan, A.W.; Ebtehaj, S.; Eftekhari, A.; Eftekharzadeh, S.; Ekholuenetale, M.; El Nahas, N.; Elgendy, I.Y.; Elhadi, M.; El-Jaafary, S.I.; Esteghamati, S.; Etisso, A.E.; Eyawo, O.; Fadhil, I.; Faraon, E.J.A.; Faris, P.S.; Farwati, M.; Farzadfar, F.; Fernandes, E.; Fernandez Prendes, C.; Ferrara, P.; Filip, I.; Fischer, F.; Flood, D.; Fukumoto, T.; Gad, M.M.; Gaidhane, S.; Ganji, M.; Garg, J.; Gebre, A.K.; Gebregiorgis, B.G.; Gebregzabiher, K.Z.; Gebremeskel, G.G.; Getacher, L.; Obsa, A.G.; Ghajar, A.; Ghashghaee, A.; Ghith, N.; Giampaoli, S.; Gilani, S.A.; Gill, P.S.; Gillum, R.F.; Glushkova, E.V.; Gnedovskaya, E.V.; Golechha, M.; Gonfa, K.B.; Goudarzian, A.H.; Goulart, A.C.; Guadamuz, J.S.; Guha, A.; Guo, Y.; Gupta, R.; Hachinski, V.; Hafezi-Nejad, N.; Haile, T.G.; Hamadeh, R.R.; Hamidi, S.; Hankey, G.J.; Hargono, A.; Hartono, R.K.; Hashemian, M.; Hashi, A.; Hassan, S.; Hassen, H.Y.; Havmoeller, R.J.; Hay, S.I.; Hayat, K.; Heidari, G.; Herteliu, C.; Holla, R.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Huang, J.; Humayun, A.; Iavicoli, I.; Ibeneme, C.U.; Ibitoye, S.E.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Iqbal, U.; Irvani, S.S.N.; Islam, S.M.S.; Islam, R.M.; Iso, H.; Iwagami, M.; Jain, V.; Javaheri, T.; Jayapal, S.K.; Jayaram, S.; Jayawardena, R.; Jeemon, P.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joukar, F.; Jozwiak, J.J.; Jürisson, M.; Kabir, A.; Kahlon, T.; Kalani, R.; Kalhor, R.; Kamath, A.; Kamel, I.; Kandel, H.; Kandel, A.; Karch, A.; Kasa, A.S.; Katoto, P.D.M.C.; Kayode, G.A.; Khader, Y.S.; Khammarnia, M.; Khan, M.S.; Khan, M.N.; Khan, M.; Khan, E.A.; Khatab, K.; Kibria, G.M.A.; Kim, Y.J.; Kim, G.R.; Kimokoti, R.W.; Kisa, S.; Kisa, A.; Kivimäki, M.; Kolte, D.; Koolivand, A.; Korshunov, V.A.; Koulmane Laxminarayana, S.L.; Koyanagi, A.; Krishan, K.; Krishnamoorthy, V.; Kuate Defo, B.; Kucuk Bicer, B.; Kulkarni, V.; Kumar, G.A.; Kumar, N.; Kurmi, O.P.; Kusuma, D.; Kwan, G.F.; La Vecchia, C.; Lacey, B.; Lallukka, T.; Lan, Q.; Lasrado, S.; Lassi, Z.S.; Lauriola, P.; Lawrence, W.R.; Laxmaiah, A.; LeGrand, K.E.; Li, M-C.; Li, B.; Li, S.; Lim, S.S.; Lim, L-L.; Lin, H.; Lin, Z.; Lin, R-T.; Liu, X.; Lopez, A.D.; Lorkowski, S.; Lotufo, P.A.; Lugo, A.; M, N.K.; Madotto, F.; Mahmoudi, M.; Majeed, A.; Malekzadeh, R.; Malik, A.A.; Mamun, A.A.; Manafi, N.; Mansournia, M.A.; Mantovani, L.G.; Martini, S.; Mathur, M.R.; Mazzaglia, G.; Mehata, S.; Mehndiratta, M.M.; Meier, T.; Menezes, R.G.; Meretoja, A.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Miller, T.R.; Mirrakhimov, E.M.; Mirzaei, H.; Moazen, B.; Moghadaszadeh, M.; Mohammad, Y.; Mohammad, D.K.; Mohammed, S.; Mohammed, M.A.; Mokhayeri, Y.; Molokhia, M.; Montasir, A.A.; Moradi, G.; Moradzadeh, R.; Moraga, P.; Morawska, L.; Moreno Velásquez, I.; Morze, J.; Mubarik, S.; Muruet, W.; Musa, K.I.; Nagarajan, A.J.; Nalini, M.; Nangia, V.; Naqvi, A.A.; Narasimha Swamy, S.; Nascimento, B.R.; Nayak, V.C.; Nazari, J.; Nazarzadeh, M.; Negoi, R.I.; Neupane Kandel, S.; Nguyen, H.L.T.; Nixon, M.R.; Norrving, B.; Noubiap, J.J.; Nouthe, B.E.; Nowak, C.; Odukoya, O.O.; Ogbo, F.A.; Olagunju, A.T.; Orru, H.; Ortiz, A.; Ostroff, S.M.; Padubidri, J.R.; Palladino, R.; Pana, A.; Panda-Jonas, S.; Parekh, U.; Park, E-C.; Parvizi, M.; Pashazadeh Kan, F.; Patel, U.K.; Pathak, M.; Paudel, R.; Pepito, V.C.F.; Perianayagam, A.; Perico, N.; Pham, H.Q.; Pilgrim, T.; Piradov, M.A.; Pishgar, F.; Podder, V.; Polibin, R.V.; Pourshams, A.; Pribadi, D.R.A.; Rabiee, N.; Rabiee, M.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi-Movaghar, V.; Ur Rahman, M.H.; Rahman, M.A.; Rahmani, A.M.; Rakovac, I.; Ram, P.; Ramalingam, S.; Rana, J.; Ranasinghe, P.; Rao, S.J.; Rathi, P.; Rawal, L.; Rawasia, W.F.; Rawassizadeh, R.; Remuzzi, G.; Renzaho, A.M.N.; Rezapour, A.; Riahi, S.M.; Roberts-Thomson, R.L.; Roever, L.; Rohloff, P.; Romoli, M.; Roshandel, G.; Rwegerera, G.M.; Saadatagah, S.; Saber-Ayad, M.M.; Sabour, S.; Sacco, S.; Sadeghi, M.; Saeedi Moghaddam, S.; Safari, S.; Sahebkar, A.; Salehi, S.; Salimzadeh, H.; Samaei, M.; Samy, A.M.; Santos, I.S.; Santric-Milicevic, M.M.; Sarrafzadegan, N.; Sarveazad, A.; Sathish, T.; Sawhney, M.; Saylan, M.; Schmidt, M.I.; Schutte, A.E.; Senthilkumaran, S.; Sepanlou, S.G.; Sha, F.; Shahabi, S.; Shahid, I.; Shaikh, M.A.; Shamali, M.; Shamsizadeh, M.; Shawon, M.S.R.; Sheikh, A.; Shigematsu, M.; Shin, M-J.; Shin, J.I.; Shiri, R.; Shiue, I.; Shuval, K.; Siabani, S.; Siddiqi, T.J.; Silva, D.A.S.; Singh, J.A.; Mtech, A.S.; Skryabin, V.Y.; Skryabina, A.A.; Soheili, A.; Spurlock, E.E.; Stockfelt, L.; Stortecky, S.; Stranges, S.; Suliankatchi Abdulkader, R.; Tadbiri, H.; Tadesse, E.G.; Tadesse, D.B.; Tajdini, M.; Tariqujjaman, M.; Teklehaimanot, B.F.; Temsah, M-H.; Tesema, A.K.; Thakur, B.; Thankappan, K.R.; Thapar, R.; Thrift, A.G.; Timalsina, B.; Tonelli, M.; Touvier, M.; Tovani-Palone, M.R.; Tripathi, A.; Tripathy, J.P.; Truelsen, T.C.; Tsegay, G.M.; Tsegaye, G.W.; Tsilimparis, N.; Tusa, B.S.; Tyrovolas, S.; Umapathi, K.K.; Unim, B.; Unnikrishnan, B.; Usman, M.S.; Vaduganathan, M.; Valdez, P.R.; Vasankari, T.J.; Velazquez, D.Z.; Venketasubramanian, N.; Vu, G.T.; Vujcic, I.S.; Waheed, Y.; Wang, Y.; Wang, F.; Wei, J.; Weintraub, R.G.; Weldemariam, A.H.; Westerman, R.; Winkler, A.S.; Wiysonge, C.S.; Wolfe, C.D.A.; Wubishet, B.L.; Xu, G.; Yadollahpour, A.; Yamagishi, K.; Yan, L.L.; Yandrapalli, S.; Yano, Y.; Yatsuya, H.; Yeheyis, T.Y.; Yeshaw, Y.; Yilgwan, C.S.; Yonemoto, N.; Yu, C.; Yusefzadeh, H.; Zachariah, G.; Zaman, S.B.; Zaman, M.S.; Zamanian, M.; Zand, R.; Zandifar, A.; Zarghi, A.; Zastrozhin, M.S.; Zastrozhina, A.; Zhang, Z-J.; Zhang, Y.; Zhang, W.; Zhong, C.; Zou, Z.; Zuniga, Y.M.H.; Murray, C.J.L.; Fuster, V. Global burden of cardiovascular diseases and risk factors, 1990-2019. J. Am. Coll. Cardiol., 2020, 76(25), 2982-3021.
[http://dx.doi.org/10.1016/j.jacc.2020.11.010] [PMID: 33309175]

Dai, H.; Much, A.A.; Maor, E.; Asher, E.; Younis, A.; Xu, Y.; Lu, Y.; Liu, X.; Shu, J.; Bragazzi, N.L. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: Results from the Global Burden of Disease Study 2017. Eur. Heart J. Qual. Care Clin. Outcomes, 2022, 8(1), 50-60.
[http://dx.doi.org/10.1093/ehjqcco/qcaa076] [PMID: 33017008]

Knuuti, J.; Wijns, W.; Saraste, A.; Capodanno, D.; Barbato, E.; Funck-Brentano, C.; Prescott, E.; Storey, R.F.; Deaton, C.; Cuisset, T.; Agewall, S.; Dickstein, K.; Edvardsen, T.; Escaned, J.; Gersh, B.J.; Svitil, P.; Gilard, M.; Hasdai, D.; Hatala, R.; Mahfoud, F.; Masip, J.; Muneretto, C.; Valgimigli, M.; Achenbach, S.; Bax, J.J.; Neumann, F-J.; Sechtem, U.; Banning, A.P.; Bonaros, N.; Bueno, H.; Bugiardini, R.; Chieffo, A.; Crea, F.; Czerny, M.; Delgado, V.; Dendale, P.; Flachskampf, F.A.; Gohlke, H.; Grove, E.L.; James, S.; Katritsis, D.; Landmesser, U.; Lettino, M.; Matter, C.M.; Nathoe, H.; Niessner, A.; Patrono, C.; Petronio, A.S.; Pettersen, S.E.; Piccolo, R.; Piepoli, M.F.; Popescu, B.A.; Räber, L.; Richter, D.J.; Roffi, M.; Roithinger, F.X.; Shlyakhto, E.; Sibbing, D.; Silber, S.; Simpson, I.A.; Sousa-Uva, M.; Vardas, P.; Witkowski, A.; Zamorano, J.L.; Achenbach, S.; Agewall, S.; Barbato, E.; Bax, J.J.; Capodanno, D.; Cuisset, T.; Deaton, C.; Dickstein, K.; Edvardsen, T.; Escaned, J.; Funck-Brentano, C.; Gersh, B.J.; Gilard, M.; Hasdai, D.; Hatala, R.; Mahfoud, F.; Masip, J.; Muneretto, C.; Prescott, E.; Saraste, A.; Storey, R.F.; Svitil, P.; Valgimigli, M.; Windecker, S.; Aboyans, V.; Baigent, C.; Collet, J-P.; Dean, V.; Delgado, V.; Fitzsimons, D.; Gale, C.P.; Grobbee, D.; Halvorsen, S.; Hindricks, G.; Iung, B.; Jüni, P.; Katus, H.A.; Landmesser, U.; Leclercq, C.; Lettino, M.; Lewis, B.S.; Merkely, B.; Mueller, C.; Petersen, S.; Petronio, A.S.; Richter, D.J.; Roffi, M.; Shlyakhto, E.; Simpson, I.A.; Sousa-Uva, M.; Touyz, R.M.; Benkhedda, S.; Metzler, B.; Sujayeva, V.; Cosyns, B.; Kusljugic, Z.; Velchev, V.; Panayi, G.; Kala, P.; Haahr-Pedersen, S.A.; Kabil, H.; Ainla, T.; Kaukonen, T.; Cayla, G.; Pagava, Z.; Woehrle, J.; Kanakakis, J.; Tóth, K.; Gudnason, T.; Peace, A.; Aronson, D.; Riccio, C.; Elezi, S.; Mirrakhimov, E.; Hansone, S.; Sarkis, A.; Babarskiene, R.; Beissel, J.; Maempel, A.J.C.; Revenco, V.; de Grooth, G.J.; Pejkov, H.; Juliebø, V.; Lipiec, P.; Santos, J.; Chioncel, O.; Duplyakov, D.; Bertelli, L.; Dikic, A.D. Studenčan, M.; Bunc, M.; Alfonso, F.; Bäck, M.; Zellweger, M.; Addad, F.; Yildirir, A.; Sirenko, Y.; Clapp, B. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J., 2020, 41(3), 407-477.
[http://dx.doi.org/10.1093/eurheartj/ehz425] [PMID: 31504439]

Chistiakov, D.A.; Sobenin, I.A.; Orekhov, A.N. Vascular extracellular matrix in atherosclerosis. Cardiol. Rev., 2013, 21(6), 270-288.
[http://dx.doi.org/10.1097/CRD.0b013e31828c5ced] [PMID: 23422022]

Steinberg, D.; Witztum, J.L. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2010, 30(12), 2311-2316.
[http://dx.doi.org/10.1161/ATVBAHA.108.179697] [PMID: 21084697]

Gimbrone, M.A., Jr; García-Cardeña, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res., 2016, 118(4), 620-636.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306301] [PMID: 26892962]

Theofilis, P.; Sagris, M.; Oikonomou, E.; Antonopoulos, A.S.; Siasos, G.; Tsioufis, C.; Tousoulis, D. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines, 2021, 9(7), 781.
[http://dx.doi.org/10.3390/biomedicines9070781] [PMID: 34356845]

Sagris, M.; Theofilis, P.; Antonopoulos, A.S.; Tsioufis, C.; Oikonomou, E.; Antoniades, C.; Crea, F.; Kaski, J.C.; Tousoulis, D. Inflammatory mechanisms in COVID-19 and atherosclerosis: Current pharmaceutical perspectives. Int. J. Mol. Sci., 2021, 22(12), 6607.
[http://dx.doi.org/10.3390/ijms22126607] [PMID: 34205487]

Nowak, W.N.; Deng, J.; Ruan, X.Z.; Xu, Q. Reactive oxygen species generation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2017, 37(5), e41-e52.
[http://dx.doi.org/10.1161/ATVBAHA.117.309228] [PMID: 28446473]

Oikonomou, E.; Leopoulou, M.; Theofilis, P.; Antonopoulos, A.S.; Siasos, G.; Latsios, G.; Mystakidi, V.C.; Antoniades, C.; Tousoulis, D. A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications. Atherosclerosis, 2020, 309, 16-26.
[http://dx.doi.org/10.1016/j.atherosclerosis.2020.07.027] [PMID: 32858395]

Miano, J.M.; Fisher, E.A.; Majesky, M.W. Fate and state of vascular smooth muscle cells in atherosclerosis. Circulation, 2021, 143(21), 2110-2116.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.120.049922] [PMID: 34029141]

Gomez, D.; Owens, G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res., 2012, 95(2), 156-164.
[http://dx.doi.org/10.1093/cvr/cvs115] [PMID: 22406749]

Shankman, L.S.; Gomez, D.; Cherepanova, O.A.; Salmon, M.; Alencar, G.F.; Haskins, R.M.; Swiatlowska, P.; Newman, A.A.C.; Greene, E.S.; Straub, A.C.; Isakson, B.; Randolph, G.J.; Owens, G.K. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat. Med., 2015, 21(6), 628-637.
[http://dx.doi.org/10.1038/nm.3866] [PMID: 25985364]

Kolodgie, F.D.; Burke, A.P.; Farb, A.; Gold, H.K.; Yuan, J.; Narula, J.; Finn, A.V.; Virmani, R. The thin-cap fibroatheroma: A type of vulnerable plaque: The major precursor lesion to acute coronary syndromes. Curr. Opin. Cardiol., 2001, 16(5), 285-292.
[http://dx.doi.org/10.1097/00001573-200109000-00006] [PMID: 11584167]

Ruddy, J.M.; Ikonomidis, J.S.; Jones, J.A. Multidimensional contribution of matrix metalloproteinases to atherosclerotic plaque vulnerability: Multiple mechanisms of inhibition to promote stability. J. Vasc. Res., 2016, 53(1-2), 1-16.
[http://dx.doi.org/10.1159/000446703] [PMID: 27327039]

Bäck, M.; Ketelhuth, D.F.J.; Agewall, S. Matrix metalloproteinases in atherothrombosis. Prog. Cardiovasc. Dis., 2010, 52(5), 410-428.
[http://dx.doi.org/10.1016/j.pcad.2009.12.002] [PMID: 20226959]

Chen, Q.; Jin, M.; Yang, F.; Zhu, J.; Xiao, Q.; Zhang, L. Matrix metalloproteinases: Inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm., 2013, 2013, 928315.
[http://dx.doi.org/10.1155/2013/928315] [PMID: 23840100]

Brauer, P.R. MMPs-role in cardiovascular development and disease. Front. Biosci., 2006, 11(1), 447-478.
[http://dx.doi.org/10.2741/1810] [PMID: 16146744]

Ikeda, U.; Shimada, K. Matrix metalloproteinases and coronary artery diseases. Clin. Cardiol., 2003, 26(2), 55-59.
[http://dx.doi.org/10.1002/clc.4960260203] [PMID: 12625594]

Choudhary, S.; Higgins, C.L.; Chen, I.Y.; Reardon, M.; Lawrie, G.; Vick, G.W., III; Karmonik, C.; Via, D.P.; Morrisett, J.D. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler. Thromb. Vasc. Biol., 2006, 26(10), 2351-2358.
[http://dx.doi.org/10.1161/01.ATV.0000239461.87113.0b] [PMID: 16888239]

Libby, P. Collagenases and cracks in the plaque. J. Clin. Invest., 2013, 123(8), 3201-3203.
[http://dx.doi.org/10.1172/JCI67526] [PMID: 23908120]

Galis, Z.S.; Muszynski, M.; Sukhova, G.K.; Simon-Morrissey, E.; Libby, P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. N. Y. Acad. Sci., 1994, 748(1), 501-507.
[http://dx.doi.org/10.1111/j.1749-6632.1994.tb17348.x] [PMID: 7695193]

Wen, G.; Zhang, C.; Chen, Q.; Luong, L.A.; Mustafa, A.; Ye, S.; Xiao, Q. A novel role of matrix metalloproteinase-8 in macrophage differentiation and polarization. J. Biol. Chem., 2015, 290(31), 19158-19172.
[http://dx.doi.org/10.1074/jbc.M114.634022] [PMID: 26092731]

Lin, J.; Kakkar, V.; Lu, X. Impact of matrix metalloproteinases on atherosclerosis. Curr. Drug Targets, 2014, 15(4), 442-453.
[http://dx.doi.org/10.2174/1389450115666140211115805] [PMID: 24517161]

Spiegel, S.; Foster, D.; Kolesnick, R. Signal transduction through lipid second messengers. Curr. Opin. Cell Biol., 1996, 8(2), 159-167.
[http://dx.doi.org/10.1016/S0955-0674(96)80061-5] [PMID: 8791422]

Morillas, P.; Quiles, J.; de Andrade, H.; Castillo, J.; Tarazón, E.; Roselló, E.; Portolés, M.; Rivera, M.; Bertomeu-Martínez, V. Circulating biomarkers of collagen metabolism in arterial hypertension. J. Hypertens., 2013, 31(8), 1611-1617.
[http://dx.doi.org/10.1097/HJH.0b013e3283614c1c] [PMID: 23615327]

Kostov, K.; Blazhev, A. Changes in serum levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in patients with essential hypertension. Bioengineering, 2022, 9(3), 119.
[http://dx.doi.org/10.3390/bioengineering9030119] [PMID: 35324807]

Boumiza, S.; Chahed, K.; Tabka, Z.; Jacob, M.P.; Norel, X.; Ozen, G. MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity. Sci. Rep., 2021, 11(1), 20052.
[http://dx.doi.org/10.1038/s41598-021-99577-2] [PMID: 34625635]

Tanindi, A.; Sahinarslan, A.; Elbeg, S.; Cemri, M. Relationship between MMP-1, MMP-9, TIMP-1, IL-6 and risk factors, clinical presentation, extent and severity of atherosclerotic coronary artery disease. Open Cardiovasc. Med. J., 2011, 5(1), 110-116.
[http://dx.doi.org/10.2174/1874192401105010110] [PMID: 21772929]

Polonskaya, Y.V.; Kashtanova, E.V.; Murashov, I.S.; Striukova, E.V.; Kurguzov, A.V.; Stakhneva, E.M.; Shramko, V.S.; Maslatsov, N.A.; Chernyavsky, A.M.; Ragino, Y.I. Association of matrix metalloproteinases with coronary artery calcification in patients with CHD. J. Pers. Med., 2021, 11(6), 506.
[http://dx.doi.org/10.3390/jpm11060506] [PMID: 34205079]

Lehrke, M.; Greif, M.; Broedl, U.C.; Lebherz, C.; Laubender, R.P.; Becker, A.; von Ziegler, F.; Tittus, J.; Reiser, M.; Becker, C.; Göke, B.; Steinbeck, G.; Leber, A.W.; Parhofer, K.G. MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovasc. Diabetol., 2009, 8(1), 50.
[http://dx.doi.org/10.1186/1475-2840-8-50] [PMID: 19751510]

Rabkin, S.W. The role matrix metalloproteinases in the production of aortic aneurysm. Prog. Mol. Biol. Transl. Sci., 2017, 147, 239-265.
[http://dx.doi.org/10.1016/bs.pmbts.2017.02.002] [PMID: 28413030]

Bayoglu, B.; Arslan, C.; Tel, C.; Ulutin, T.; Dirican, A.; Deser, S.B.; Cengiz, M. Genetic variants rs1994016 and rs3825807 in ADAMTS7 affect its mRNA expression in atherosclerotic occlusive peripheral arterial disease. J. Clin. Lab. Anal., 2018, 32(1), e22174.
[http://dx.doi.org/10.1002/jcla.22174] [PMID: 28205274]

Gonçalves, F.M.; Jacob-Ferreira, A.L.B.; Gomes, V.A.; Casella-Filho, A.; Chagas, A.C.P.; Marcaccini, A.M.; Gerlach, R.F.; Tanus-Santos, J.E. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clin. Chim. Acta, 2009, 403(1-2), 173-177.
[http://dx.doi.org/10.1016/j.cca.2009.02.013] [PMID: 19254704]

Kato, R.; Momiyama, Y.; Ohmori, R.; Taniguchi, H.; Nakamura, H.; Ohsuzu, F. Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease. Circ. J., 2005, 69(9), 1035-1040.
[http://dx.doi.org/10.1253/circj.69.1035] [PMID: 16127182]

Allal-Elasmi, M.; Zayani, Y.; Zidi, W.; Zaroui, A.; Feki, M.; Mourali, S.; Mechmeche, R.; Kaabachi, N. The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome. Clin. Lab., 2014, 60(06/2014), 951-956.
[http://dx.doi.org/10.7754/Clin.Lab.2013.130346] [PMID: 25016699]

Momiyama, Y.; Ohmori, R.; Tanaka, N.; Kato, R.; Taniguchi, H.; Adachi, T.; Nakamura, H.; Ohsuzu, F. High plasma levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis, 2010, 209(1), 206-210.
[http://dx.doi.org/10.1016/j.atherosclerosis.2009.07.037] [PMID: 19674746]

Tuomainen, A.M.; Kormi, I.; Havulinna, A.S.; Tervahartiala, T.; Salomaa, V.; Sorsa, T.; Pussinen, P.J. Serum tissue-degrading proteinases and incident cardiovascular disease events. Eur. J. Prev. Cardiol., 2014, 21(7), 806-812.
[http://dx.doi.org/10.1177/2047487312465524] [PMID: 23079500]

Fertin, M.; Lemesle, G.; Turkieh, A.; Beseme, O.; Chwastyniak, M.; Amouyel, P.; Bauters, C.; Pinet, F. Serum MMP-8: A novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction. PLoS One, 2013, 8(8), e71280.
[http://dx.doi.org/10.1371/journal.pone.0071280] [PMID: 23967183]

Guizani, I.; Zidi, W.; Zayani, Y.; Boudiche, S.; Hadj-Taieb, S.; Sanhaji, H.; Zaroui, A.; Mechmeche, R.; Mourali, M.S.; Feki, M.; Allal-Elasmi, M. Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: A 5 years cohort study. Mol. Biol. Rep., 2019, 46(5), 4699-4707.
[http://dx.doi.org/10.1007/s11033-019-04914-4] [PMID: 31218540]

Lau, E.S.; Paniagua, S.M.; Guseh, J.S.; Bhambhani, V.; Zanni, M.V.; Courchesne, P.; Lyass, A.; Larson, M.G.; Levy, D.; Ho, J.E. Sex differences in circulating biomarkers of cardiovascular disease. J. Am. Coll. Cardiol., 2019, 74(12), 1543-1553.
[http://dx.doi.org/10.1016/j.jacc.2019.06.077] [PMID: 31537263]

Salminen, A.; Vlachopoulou, E.; Havulinna, A.S.; Tervahartiala, T.; Sattler, W.; Lokki, M.L.; Nieminen, M.S.; Perola, M.; Salomaa, V.; Sinisalo, J.; Meri, S.; Sorsa, T.; Pussinen, P.J. Genetic variants contributing to circulating matrix metalloproteinase 8 levels and their association with cardiovascular diseases. Circ. Cardiovasc. Genet., 2017, 10(6), e001731.
[http://dx.doi.org/10.1161/CIRCGENETICS.117.001731] [PMID: 29212897]

Suzuki, H.; Kusuyama, T.; Sato, R.; Yokota, Y.; Tsunoda, F.; Sato, T.; Shoji, M.; Iso, Y.; Koba, S.; Katagiri, T. Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction. Eur. J. Clin. Invest., 2008, 38(3), 166-173.
[http://dx.doi.org/10.1111/j.1365-2362.2007.01919.x] [PMID: 18257779]

Minukhina, D.; Zaikina, T.; Koteliukh, M.; Titova, G.; Zolotaikina, V. Impact of percutaneous coronary intervention on markers of matrix degradation and endothelial-dependent mediators in patients with acute myocardial infarction and diabetes mellitus type 2. Georgian Med. News, 2020, (299), 70-74.
[PMID: 32242848]

Vašků A.; Meluzín, J.; Blahák, J.; Kincl, V.; Pávková Goldbergová, M.; Sitar, J.; Zlámal, F.; Bienertová-Vašků J.; Vítovec, J. Matrix metalloproteinase 13 genotype in rs640198 polymorphism is associated with severe coronary artery disease. Dis. Markers, 2012, 33(1), 43-49.
[http://dx.doi.org/10.1155/2012/795739] [PMID: 22710868]

Galis, Z.S.; Muszynski, M.; Sukhova, G.K.; Simon-Morrissey, E.; Unemori, E.N.; Lark, M.W.; Amento, E.; Libby, P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res., 1994, 75(1), 181-189.
[http://dx.doi.org/10.1161/01.RES.75.1.181] [PMID: 8013077]

Hanemaaijer, R.; Koolwijk, P.; le Clercq, L.; de Vree, W.J.A.; van Hinsbergh, V.W.M. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor α interleukin 1 and phorbol ester. Biochem. J., 1993, 296(3), 803-809.
[http://dx.doi.org/10.1042/bj2960803] [PMID: 8280080]

Brown, D.L.; Hibbs, M.S.; Kearney, M.; Loushin, C.; Isner, J.M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation, 1995, 91(8), 2125-2131.
[http://dx.doi.org/10.1161/01.CIR.91.8.2125] [PMID: 7697840]

Guo, Z.Y.; Zhang, B.; Yan, Y.H.; Gao, S.S.; Liu, J.J.; Xu, L.; Hui, P.J. Specific matrix metalloproteinases and calcification factors are associated with the vulnerability of human carotid plaque. Exp. Ther. Med., 2018, 16(3), 2071-2079.
[http://dx.doi.org/10.3892/etm.2018.6424] [PMID: 30186442]

Müller, A.; Krämer, S.D.; Meletta, R.; Beck, K.; Selivanova, S.V.; Rancic, Z.; Kaufmann, P.A.; Vos, B.; Meding, J.; Stellfeld, T.; Heinrich, T.K.; Bauser, M.; Hütter, J.; Dinkelborg, L.M.; Schibli, R.; Ametamey, S.M. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Nucl. Med. Biol., 2014, 41(7), 562-569.
[http://dx.doi.org/10.1016/j.nucmedbio.2014.04.085] [PMID: 24853402]

Peeters, S.A.; Engelen, L.; Buijs, J.; Jorsal, A.; Parving, H.H.; Tarnow, L.; Rossing, P.; Schalkwijk, C.G.; Stehouwer, C.D.A. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: A 12-year follow-up study. Cardiovasc. Diabetol., 2017, 16(1), 55.
[http://dx.doi.org/10.1186/s12933-017-0539-1] [PMID: 28446168]

Derosa, G.; Maffioli, P.; D’Angelo, A.; Salvadeo, S.A.T.; Ferrari, I.; Fogari, E.; Gravina, A.; Mereu, R.; Palumbo, I.; Randazzo, S.; Cicero, A.F.G. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia. Clin. Invest. Med., 2009, 32(2), 124.
[http://dx.doi.org/10.25011/cim.v32i2.6030] [PMID: 19331801]

Derosa, G.; Ferrari, I.; D’Angelo, A.; Tinelli, C.; Salvadeo, S.A.T.; Ciccarelli, L.; Piccinni, M.N.; Gravina, A.; Ramondetti, F.; Maffioli, P.; Cicero, A.F.G. Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium, 2008, 15(4), 219-224.
[http://dx.doi.org/10.1080/10623320802228815] [PMID: 18663625]

Yu, A.P.; Tam, B.T.; Yau, W.Y.; Chan, K.S.; Yu, S.S.; Chung, T.L.; Siu, P.M. Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults. Diabetol. Metab. Syndr., 2015, 7(1), 111.
[http://dx.doi.org/10.1186/s13098-015-0108-2] [PMID: 26692905]

Ezhov, M.; Safarova, M.; Afanasieva, O.; Mitroshkin, M.; Matchin, Y.; Pokrovsky, S. Matrix metalloproteinase 9 as a predictor of coronary atherosclerotic plaque instability in stable coronary heart disease patients with elevated lipoprotein(a) levels. Biomolecules, 2019, 9(4), 129.
[http://dx.doi.org/10.3390/biom9040129] [PMID: 30934954]

Kai, H.; Ikeda, H.; Yasukawa, H.; Kai, M.; Seki, Y.; Kuwahara, F.; Ueno, T.; Sugi, K.; Imaizumi, T. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol., 1998, 32(2), 368-372.
[http://dx.doi.org/10.1016/S0735-1097(98)00250-2] [PMID: 9708462]

Inokubo, Y.; Hanada, H.; Ishizaka, H.; Fukushi, T.; Kamada, T.; Okumura, K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am. Heart J., 2001, 141(2), 211-217.
[http://dx.doi.org/10.1067/mhj.2001.112238] [PMID: 11174334]

Li, C.; Zhang, Z.; Peng, Y.; Gao, H.; Wang, Y.; Zhao, J.; Pan, C. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease. PLoS One, 2019, 14(8), e0220841.
[http://dx.doi.org/10.1371/journal.pone.0220841] [PMID: 31387110]

Li, Y.; Li, L.; Wang, K.; Wu, P.; Cui, Y. Investigation on risk stratification and the prognostic value of hs-TnT combined with MMP-2 in patients with acute coronary syndrome. BioMed Res. Int., 2021, 2021, 1040171.
[http://dx.doi.org/10.1155/2021/1040171] [PMID: 34859099]

Li, Y.; Qin, L.; Bai, Q.; Zhang, J.; Chen, R.; Song, K. CD100 modulates cytotoxicity of CD8+ T cells in patients with acute myocardial infarction. BMC Immunol., 2021, 22(1), 13.
[http://dx.doi.org/10.1186/s12865-021-00406-y] [PMID: 33593275]

Dhillon, O.S.; Khan, S.Q.; Narayan, H.K.; Ng, K.H.; Mohammed, N.; Quinn, P.A.; Squire, I.B.; Davies, J.E.; Ng, L.L. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin. Sci., 2010, 118(4), 249-257.
[http://dx.doi.org/10.1042/CS20090226] [PMID: 19583569]

Hamed, G.M.; Fattah, M.F.A. Clinical relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome. Clin. Appl. Thromb. Hemost., 2015, 21(8), 705-711.
[http://dx.doi.org/10.1177/1076029614567309] [PMID: 25616488]

Goliopoulou, A.; Oikonomou, E.; Antonopoulos, A.; Koumallos, N.; Gazouli, M.; Theofilis, P.; Mystakidi, V.C.; Pantelidis, P.; Vavuranakis, M.A.; Siasos, G.; Tousoulis, D. Expression of tissue microRNAs in ascending aortic aneurysms and dissections. Angiology, 2022. [Epub ahead of print].
[http://dx.doi.org/10.1177/00033197221098295] [PMID: 35503041]

Olson, F.J.; Schmidt, C.; Gummesson, A.; Sigurdardottir, V.; Hulthe, J.; Wiklund, O.; Fagerberg, B. Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis. J. Intern. Med., 2008, 263(6), 626-635.
[http://dx.doi.org/10.1111/j.1365-2796.2008.01927.x] [PMID: 18341531]

Signorelli, S.S.; Malaponte, G.; Libra, M.; Pino, L.D.; Celotta, G.; Bevelacqua, V.; Petrina, M.; Nicotra, G.S.; Indelicato, M.; Navolanic, P.M.; Pennisi, G.; Mazzarino, M.C. Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vasc. Med., 2005, 10(1), 1-6.
[http://dx.doi.org/10.1191/1358863x05vm582oa] [PMID: 15920993]

Henney, A.M.; Wakeley, P.R.; Davies, M.J.; Foster, K.; Hembry, R.; Murphy, G.; Humphries, S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci., 1991, 88(18), 8154-8158.
[http://dx.doi.org/10.1073/pnas.88.18.8154] [PMID: 1896464]

Silence, J.; Lupu, F.; Collen, D.; Lijnen, H.R. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler. Thromb. Vasc. Biol., 2001, 21(9), 1440-1445.
[http://dx.doi.org/10.1161/hq0901.097004] [PMID: 11557669]

Rodriguez, J.A.; Orbe, J.; Martinez de Lizarrondo, S.; Calvayrac, O.; Rodriguez, C.; Martinez-Gonzalez, J.; Paramo, J.A. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front. Biosci., 2008, 13(13), 2916-2921.
[http://dx.doi.org/10.2741/2896] [PMID: 17981764]

van der Leeuw, J.; Beulens, J.W.J.; van Dieren, S.; Schalkwijk, C.G.; Glatz, J.F.C.; Hofker, M.H.; Verschuren, W.M.M.; Boer, J.M.A.; van der Graaf, Y.; Visseren, F.L.J.; Peelen, L.M.; van der Schouw, Y.T. Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus. J. Am. Heart Assoc., 2016, 5(6), e003048.
[http://dx.doi.org/10.1161/JAHA.115.003048] [PMID: 27247335]

Wu, T.C.; Leu, H.B.; Lin, W.T.; Lin, C.P.; Lin, S.J.; Chen, J.W. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Eur. J. Clin. Invest., 2005, 35(9), 537-545.
[http://dx.doi.org/10.1111/j.1365-2362.2005.01548.x] [PMID: 16128859]

Kelly, D.; Khan, S.; Cockerill, G.; Ng, L.L.; Thompson, M.; Samani, N.J.; Squire, I.B. Circulating stromelysin-1 (MMP-3): A novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur. J. Heart Fail., 2008, 10(2), 133-139.
[http://dx.doi.org/10.1016/j.ejheart.2007.12.009] [PMID: 18234553]

Cavusoglu, E.; Marmur, J.D.; Kassotis, J.T.; Yanamadala, S.; Chopra, V.; Eng, C. Usefulness of plasma matrix metalloproteinase-3 levels to predict myocardial infarction in men with and without acute coronary syndrome. Am. J. Cardiol., 2016, 117(6), 881-886.
[http://dx.doi.org/10.1016/j.amjcard.2015.12.022] [PMID: 26805660]

Lien, L.M.; Hsieh, Y.C.; Bai, C.H.; Chen, W.H.; Chiu, H.C.; Hsieh, F.I.; Shyu, K.G.; Chiou, H.Y.; Hsu, C.Y. Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis, 2010, 212(2), 595-600.
[http://dx.doi.org/10.1016/j.atherosclerosis.2010.05.040] [PMID: 20609440]

Carrell, T.W.G.; Burnand, K.G.; Wells, G.M.A.; Clements, J.M.; Smith, A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation, 2002, 105(4), 477-482.
[http://dx.doi.org/10.1161/hc0402.102621] [PMID: 11815431]

Páramo, J.A.; Beloqui, O.; Rodríguez, J.A.; Diez, J.; Orbe, J. Association between matrix metalloproteinase-10 concentration and smoking in individuals without cardiovascular disease. Rev. Esp. Cardiol., 2008, 61(12), 1267-1273.
[PMID: 19080965]

Orbe, J.; Montero, I.; Rodríguez, J.A.; Beloqui, O.; Roncal, C.; Páramo, J.A. Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J. Thromb. Haemost., 2007, 5(1), 91-97.
[http://dx.doi.org/10.1111/j.1538-7836.2006.02276.x] [PMID: 17059420]

Coll, B.; Rodríguez, J.A.; Craver, L.; Orbe, J.; Martínez-Alonso, M.; Ortiz, A.; Díez, J.; Beloqui, O.; Borras, M.; Valdivielso, J.M.; Fernández, E.; Páramo, J.A. Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease. Kidney Int., 2010, 78(12), 1275-1280.
[http://dx.doi.org/10.1038/ki.2010.329] [PMID: 20844474]

Martinez-Aguilar, E.; Gomez-Rodriguez, V.; Orbe, J.; Rodriguez, J.A.; Fernández-Alonso, L.; Roncal, C.; Páramo, J.A. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease. J. Vasc. Surg., 2015, 61(2), 428-435.
[http://dx.doi.org/10.1016/j.jvs.2014.09.002] [PMID: 25441671]

Nilsson, L.; Jonasson, L.; Nijm, J.; Hamsten, A.; Eriksson, P. Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin. Chem., 2006, 52(8), 1522-1527.
[http://dx.doi.org/10.1373/clinchem.2006.067439] [PMID: 16762997]

Moreno-Ajona, D.; Irimia, P.; Rodríguez, J.A.; García-Velloso, M.J.; López-Fidalgo, J.; Fernández-Alonso, L.; Grochowitz, L.; Muñoz, R.; Domínguez, P.; Gállego-Culleré, J.; Martínez-Vila, E. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study. BMC Cardiovasc. Disord., 2020, 20(1), 93.
[http://dx.doi.org/10.1186/s12872-020-01387-3] [PMID: 32101136]

Uzui, H.; Harpf, A.; Liu, M.; Doherty, T.M.; Shukla, A.; Chai, N.N.; Tripathi, P.V.; Jovinge, S.; Wilkin, D.J.; Asotra, K.; Shah, P.K.; Rajavashisth, T.B. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: Role of activated macrophages and inflammatory cytokines. Circulation, 2002, 106(24), 3024-3030.
[http://dx.doi.org/10.1161/01.CIR.0000041433.94868.12] [PMID: 12473546]

Barasch, E.; Gottdiener, J.S.; Aurigemma, G.; Kitzman, D.W.; Han, J.; Kop, W.J.; Tracy, R.P. The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: The cardiovascular health study. Circ. Heart Fail., 2011, 4(6), 733-739.
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.111.962027] [PMID: 21900186]

Duprez, D.A.; Gross, M.D.; Sanchez, O.A.; Kizer, J.R.; Ix, J.H.; Lima, J.; Tracy, R.P.; Jacobs, D.R., Jr Collagen turnover markers in relation to future cardiovascular and noncardiovascular disease: The multi-ethnic study of atherosclerosis. Clin. Chem., 2017, 63(7), 1237-1247.
[http://dx.doi.org/10.1373/clinchem.2016.270520] [PMID: 28515098]

Manhenke, C.; Ørn, S.; Squire, I.; Radauceanu, A.; Alla, F.; Zannad, F.; Dickstein, K. The prognostic value of circulating markers of collagen turnover after acute myocardial infarction. Int. J. Cardiol., 2011, 150(3), 277-282.
[http://dx.doi.org/10.1016/j.ijcard.2010.04.034] [PMID: 20493567]

Otaki, Y.; Watanabe, T.; Takahashi, H.; Yamaura, G.; Nishiyama, S.; Arimoto, T.; Shishido, T.; Miyamoto, T.; Kubota, I. Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy. Heart Vessels, 2017, 32(2), 149-156.
[http://dx.doi.org/10.1007/s00380-016-0858-2] [PMID: 27251570]

Holm Nielsen, S.; Tengryd, C.; Edsfeldt, A.; Brix, S.; Genovese, F.; Bengtsson, E.; Karsdal, M.; Leeming, D.J.; Nilsson, J.; Goncalves, I. A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis. J. Intern. Med., 2019, 285(1), 118-123.
[http://dx.doi.org/10.1111/joim.12819] [PMID: 30156050]

Bertelsen, D.M.; Neergaard, J.S.; Bager, C.L.; Nielsen, S.H.; Secher, N.H.; Svendsen, J.H.; Bihlet, A.R.; Andersen, J.R.; Karsdal, M.A.; Christiansen, C.; Nielsen, H.B. Matrix metalloproteinase mediated type I collagen degradation is an independent predictor of increased risk of acute myocardial infarction in postmenopausal women. Sci. Rep., 2018, 8(1), 5371.
[http://dx.doi.org/10.1038/s41598-018-23458-4] [PMID: 29599489]

Wang, H.; Liu, D.; Zhang, H. Investigation of the underlying genes and mechanism of macrophage-enriched ruptured atherosclerotic plaques using bioinformatics method. J. Atheroscler. Thromb., 2019, 26(7), 636-658.
[http://dx.doi.org/10.5551/jat.45963] [PMID: 30643084]

Bode, M.K.; Mosorin, M.; Satta, J.; Risteli, L.; Juvonen, T.; Risteli, J. Complete processing of type III collagen in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol., 1999, 19(6), 1506-1511.
[http://dx.doi.org/10.1161/01.ATV.19.6.1506] [PMID: 10364082]

Kong, C.H.; Lin, X.Y.; Woo, C.C.; Wong, H.C.; Lee, C.N.; Richards, A.M.; Sorokin, V.A. Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: Tissue microarray detection of collagen I, collagen III and elastin levels. Interact. Cardiovasc. Thorac. Surg., 2013, 16(1), 11-15.
[http://dx.doi.org/10.1093/icvts/ivs421] [PMID: 23049084]

Velagaleti, R.S.; Gona, P.; Sundström, J.; Larson, M.G.; Siwik, D.; Colucci, W.S.; Benjamin, E.J.; Vasan, R.S. Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality. Arterioscler. Thromb. Vasc. Biol., 2010, 30(11), 2283-2288.
[http://dx.doi.org/10.1161/ATVBAHA.110.208462] [PMID: 20798380]

Nishimura, M.; Tokoro, T.; Takatani, T.; Sato, N.; Hashimoto, T.; Kobayashi, H.; Ono, T. Circulating aminoterminal propeptide of Type III procollagen as a biomarker of cardiovascular events in patients undergoing hemodialysis. J. Atheroscler. Thromb., 2019, 26(4), 340-350.
[http://dx.doi.org/10.5551/jat.45138] [PMID: 30111669]

Eschalier, R.; Fertin, M.; Fay, R.; Bauters, C.; Zannad, F.; Pinet, F.; Rossignol, P. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: Insights from the REVE-2 study. Circ. Heart Fail., 2013, 6(6), 1199-1205.
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.113.000403] [PMID: 23983248]

Osokina, A.; Karetnikova, V.; Polikutina, O.; Ivanova, A.; Gruzdeva, O.; Dyleva, Y.; Kokov, A.; Brel, N.; Pecherina, T.; Barbarash, O. Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction. Aging, 2021, 13(1), 194-203.
[http://dx.doi.org/10.18632/aging.202495] [PMID: 33431713]

Lee, C.H.; Lee, W.C.; Chang, S.H.; Wen, M.S.; Hung, K.C. The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: A link between left ventricular end-diastolic pressure and cardiovascular events. PLoS One, 2015, 10(1), e114097.
[http://dx.doi.org/10.1371/journal.pone.0114097] [PMID: 25559610]

Gao, H.; Zhang, X.S.; Zhao, Q.; Ma, L.L.; Wang, L.X. Predictive value of serum collagen biomakers on the outcome of acute myocardial infarction treated with percutaneous coronary intervention. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2015, 159(2), 272-276.
[http://dx.doi.org/10.5507/bp.2013.091] [PMID: 24441293]

Stienen, S.; Rossignol, P.; Barros, A.; Girerd, N.; Pitt, B.; Zannad, F.; Ferreira, J.P. Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: Insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) and early eplerenone treatment in patients with acute st-elevation myocardial infarction without heart failure (REMINDER) trials. Clin. Res. Cardiol., 2020, 109(2), 194-204.
[http://dx.doi.org/10.1007/s00392-019-01500-3] [PMID: 31250134]

Chang, Y.Y.; Wu, Y.W.; Lee, J.K.; Lin, Y.M.; Lin, Y.T.; Kao, H.L.; Hung, C.S.; Lin, H.J.; Lin, Y.H. Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-naïve patients with hypertension with atherosclerosis. J. Investig. Med., 2016, 64(7), 1194-1199.
[http://dx.doi.org/10.1136/jim-2016-000092] [PMID: 27430242]

Wilson, K.A.; Lindholt, J.S.; Hoskins, P.R.; Heickendorff, L.; Vammen, S.; Bradbury, A.W. The relationship between abdominal aortic aneurysm distensibility and serum markers of elastin and collagen metabolism. Eur. J. Vasc. Endovasc. Surg., 2001, 21(2), 175-178.
[http://dx.doi.org/10.1053/ejvs.2001.1303] [PMID: 11237793]

Ormezzano, O.; Baguet, J.P.; Thony, F.; Blin, D.; Chavanon, O.; Toussaint, B.; Trocmé, C.; Vanzetto, G.; Faure, P. Aminoterminal propeptide of type III procollagen (PIIINP) is associated with ascending aortic aneurysm growth rate. Int. J. Cardiol., 2010, 145(2), 379-380.
[http://dx.doi.org/10.1016/j.ijcard.2010.02.051] [PMID: 20227120]

Nana, P.; Dakis, K.; Brodis, A.; Spanos, K.; Kouvelos, G. Circulating biomarkers for the prediction of abdominal aortic aneurysm growth. J. Clin. Med., 2021, 10(8), 1718.
[http://dx.doi.org/10.3390/jcm10081718] [PMID: 33923412]

Murashov, I.S.; Volkov, A.M.; Kazanskaya, G.M.; Kliver, E.E.; Savchenko, S.V.; Klochkova, S.V.; Lushnikova, E.L. Immunohistochemical phenotypes of stable and unstable occlusive atherosclerotic plaques in coronary arteries. Bull. Exp. Biol. Med., 2018, 165(6), 798-802.
[http://dx.doi.org/10.1007/s10517-018-4268-6] [PMID: 30353330]

Murata, K.; Motayama, T.; Kotake, C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis, 1986, 60(3), 251-262.
[http://dx.doi.org/10.1016/0021-9150(86)90172-3] [PMID: 3089234]

Shekhonin, B.V.; Domogatsky, S.P.; Muzykantov, V.R.; Idelson, G.L.; Rukosuev, V.S. Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: Immunomorphological characteristics. Coll. Relat. Res., 1985, 5(4), 355-368.
[http://dx.doi.org/10.1016/S0174-173X(85)80024-8] [PMID: 3902343]

Nielsen, S.H.; Mygind, N.D.; Michelsen, M.M.; Bechsgaard, D.F.; Suhrs, H.E.; Genovese, F.; Nielsen, H.B.; Brix, S.; Karsdal, M.; Prescott, E.; Kastrup, J. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy. Eur. J. Prev. Cardiol., 2018, 25(7), 719-727.
[http://dx.doi.org/10.1177/2047487318758750] [PMID: 29436257]

Holm Nielsen, S.; Tengryd, C.; Edsfeldt, A.; Brix, S.; Genovese, F.; Bengtsson, E.; Karsdal, M.; Leeming, D.J.; Nilsson, J.; Goncalves, I. Markers of basement membrane remodeling are associated with higher mortality in patients with known atherosclerosis. J. Am. Heart Assoc., 2018, 7(21), e009193.
[http://dx.doi.org/10.1161/JAHA.118.009193] [PMID: 30608207]

Rohwedder, I.; Montanez, E.; Beckmann, K.; Bengtsson, E.; Dunér, P.; Nilsson, J.; Soehnlein, O.; Fässler, R. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol. Med., 2012, 4(7), 564-576.
[http://dx.doi.org/10.1002/emmm.201200237] [PMID: 22514136]

Ekmekci, H.; Ekmekci, O.B.; Sonmez, H.; Ozturk, Z.; Domanic, N.; Kokoglu, E. Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: Impacts on thrombosis and thrombolysis. Clin. Appl. Thromb. Hemost., 2005, 11(1), 63-70.
[http://dx.doi.org/10.1177/107602960501100107] [PMID: 15678274]

Örem, C. Durmuş .; Klç, K.; Baykan, M.; Gökçe, M.; Örem, A.; Topbaş M. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Coron. Artery Dis., 2003, 14(3), 219-224.
[http://dx.doi.org/10.1097/01.mca.0000066454.28270.fb] [PMID: 12702925]

Song, K.S.; Kim, H.K.; Shim, W.; Jee, S.H. Plasma fibronectin levels in ischemic heart disease. Atherosclerosis, 2001, 154(2), 449-453.
[http://dx.doi.org/10.1016/S0021-9150(00)00490-1] [PMID: 11166778]

Vavalle, J.P.; Wu, S.S.; Hughey, R.; Madamanchi, N.R.; Stouffer, G.A. Plasma fibronectin levels and coronary artery disease. J. Thromb. Haemost., 2007, 5(4), 864-866.
[http://dx.doi.org/10.1111/j.1538-7836.2007.02420.x] [PMID: 17266699]

Zhang, Y.; Zhou, X.; Krepinsky, J.C.; Wang, C.; Segbo, J.; Zheng, F. Association study between fibronectin and coronary heart disease. Clin. Chem. Lab. Med., 2006, 44(1), 37-42.
[http://dx.doi.org/10.1515/CCLM.2006.008] [PMID: 16375583]